Seminars in Liver Disease

Papers
(The TQCC of Seminars in Liver Disease is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Critical Care Management of Acute-on-Chronic Liver Failure: Certainties and Unknowns99
A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD51
Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma36
Hepatic Extracellular Matrix and Its Role in the Regulation of Liver Phenotype34
Expert Practical Recommendations for Hepatocellular Carcinoma34
Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease28
Genetic and Epigenetic Basis of Drug-Induced Liver Injury26
HBV Biomarkers and Their Role in Guiding Treatment Decisions25
Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease23
Emerging Targets for the Treatment of Primary Sclerosing Cholangitis23
Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy22
Alcohol Plus Additional Risk Factors: Rodent Model of Liver Injury19
Growth Hormone Signaling in Liver Diseases: Therapeutic Potentials and Controversies19
Wilson Disease: Novel Diagnostic and Therapeutic Approaches18
Physiomimetic In Vitro Human Models for Viral Infection in the Liver18
Mice Engrafted with Human Liver Cells18
Patient-Derived Models of Liver Cancer to Inform Clinical Treatment Paradigms: Recent Updates17
Dietary Recommendations for the Management of Non-alcoholic Fatty Liver Disease (NAFLD): A Nutritional Geometry Perspective16
14
Diagnosis and Management of Early Stages of ALD14
Primary Cilia in Hepatic Biliary Hyperplasia: Implications for Liver Diseases12
Liver Neurobiology: Regulation of Liver Functions by the Nervous System12
Role of Intestinal Barrier Disruption to Acute-on-Chronic Liver Failure12
11
11
To TIPS or Not to TIPS in High Risk of Variceal Rebleeding and Acute-on-Chronic Liver Failure11
Role of Complement in Liver Diseases11
This Is What Metabolic Dysfunction–Associated Steatotic Liver Disease Looks Like: Potential of a Multiparametric MRI Protocol10
Management of Portal vein Thrombosis in Cirrhosis10
Endoscopic Advances in Hepatology10
Patient-Centered Treatment of Cirrhosis10
Liver Transplantation for Hepatocellular Carcinoma: A Narrative Review and A Glimpse into The Future10
Hepatitis Delta Infection: A Clinical Review10
Combined Hepatocellular-Cholangiocarcinoma: A Clinical and Molecular Review10
Mesenchymal Stem Cell Transplantation in Liver Diseases10
Novel Biomarkers of AKI in Cirrhosis10
Hepatocellular Carcinoma Chemoprevention with Generic Agents10
The Hepatic Porphyrias: Revealing the Complexities of a Rare Disease9
Noninvasive Tests to Assess Fibrosis and Disease Severity in Metabolic Dysfunction-Associated Steatotic Liver Disease9
Big Data Analytics in Large Cohorts: Opportunities and Challenges for Research in Hepatology9
Erratum to: Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy9
Pediatric and Adult Liver Disease in Alpha-1 Antitrypsin Deficiency9
LncRNAs, RNA Therapeutics, and Emerging Technologies in Liver Pathobiology9
Optimizing Liver Cancer Care Through BCLC Principles9
0.41202402114868